Clinical trials
Phase 1 Lung Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| Shiga University | 3 |
| Amgen | 2 |
| Blueprint Medicines Corporation | 2 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Boehringer Ingelheim | 1 |
| Eisai Co., Ltd. | 1 |
| Japan Multinational Trial Organization | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Breast Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Kidney Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.